Financials

News Ideas Discussions Technicals Forecast Seasonals Options

FENC fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

FENC has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company